Quantum Leap Healthcare Collaborative Announces AstraZeneca’s Olaparib And Durvalumab For The…
Quantum Leap Healthcare Collaborative™ (QLHC) announced that a new randomized, investigational treatment arm for the I-SPY 2 TRIAL™ includes the study…